Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

2
results for

"Dong Wook Kim"

Article category

Keywords

Publication year

"Dong Wook Kim"

Original Article

Non-contrast magnetic resonance imaging for detection of late recurrent hepatocellular carcinoma after curative treatment: a prospective multicenter comparison to contrast-enhanced computed tomography
Dong Wook Kim, Won Chang, So Yeon Kim, Young-Suk Lim, Jonggi Choi, Jungheum Cho, Jin-Wook Kim, Jai Young Cho, Sun Kyung Jeon, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Kyung-Suk Suh, Kwang-Woong Lee, Dong Ho Lee
Clin Mol Hepatol 2025;31(4):1285-1297.
Published online June 13, 2025
DOI: https://doi.org/10.3350/cmh.2025.0258
Background/Aims
Hepatocellular carcinoma (HCC) frequently recurs after curative treatment, posing challenges to long-term survival. Although contrast-enhanced multiphasic computed tomography (CECT) is commonly used for detecting recurrence, it is associated with risks such as radiation exposure and contrast agent reactions. This study aimed to compare the diagnostic performance of non-contrast magnetic resonance imaging (NC-MRI) with CECT for detecting recurrent HCC.
Methods
In this prospective multicenter intra-individual head-to-head comparison trial (study identifier: NCT05690451, KCT0006395), participants who had undergone curative treatment for HCC and remained recurrence-free for over two years were enrolled. Each participant underwent three follow-up imaging sessions at 2–6-month intervals using both CECT and NC-MRI. The primary outcome was the detection accuracy of each modality, analyzed using the generalized estimating equation analysis. Secondary outcomes included sensitivity and specificity.
Results
The study included 203 participants with a total of 528 paired imaging sessions, identifying recurrent HCC in 22 cases (10.8%). Among these, 21 cases involved intrahepatic recurrence with a median tumor size of 1.3 cm, and one case had aortocaval lymph node metastasis. NC-MRI achieved a detection accuracy of 96.6% (196/203), higher than CECT’s 91.6% (186/203) (P=0.006). NC-MRI also showed greater sensitivity (77.3% [17/22] vs. 36.4% [8/22]; P=0.012), while specificity was comparable between NC-MRI and CECT (98.9% [179/181] vs. 98.3% [178/181]; P=0.999).
Conclusions
NC-MRI demonstrated higher sensitivity and accuracy compared to CECT in detecting recurrent HCC in patients who had been disease-free for over two years following curative treatment, indicating its potential as a preferred imaging modality for this purpose.

Citations

Citations to this article as recorded by  Crossref logo
  • Non-contrast magnetic resonance imaging outperforms contrast-enhanced computed tomography in preoperative detection of hepatocellular carcinoma: A paired validation study
    Laizhu Zhang, Weiwei Zong, Jialin Gao, Huan Li, Leizhou Xia, Xiaoli Mai, Jun Chen, Binghua Li, Decai Yu
    Clinical and Molecular Hepatology.2026; 32(1): e34.     CrossRef
  • Updates in Abbreviated MRI‐Based HCC Surveillance
    Hyo Jung Park, So Yeon Kim, Young‐Suk Lim
    Journal of Gastroenterology and Hepatology.2026; 41(3): 914.     CrossRef
  • Moving beyond Ultrasound for Hepatocellular Carcinoma Surveillance in High-Risk Patients with Chronic Hepatitis B
    Hae Lim Lee
    Gut and Liver.2026; 20(2): 174.     CrossRef
  • Correspondence to editorial on “Non-contrast magnetic resonance imaging for detection of late recurrent hepatocellular carcinoma after curative treatment: a prospective multicenter comparison to contrast-enhanced computed tomography”
    Dong Ho Lee
    Clinical and Molecular Hepatology.2026; 32(2): e221.     CrossRef
  • Correspondence to letter to the editor on “Non-contrast magnetic resonance imaging for detection of late recurrent hepatocellular carcinoma after curative treatment: a prospective multicenter comparison to contrast-enhanced computed tomography”
    Dong Ho Lee
    Clinical and Molecular Hepatology.2026; 32(2): e251.     CrossRef
  • Beyond diagnostic accuracy: Economic and clinical considerations for NC-MRI in late HCC recurrence surveillance: Letter to the editor on “Non-contrast magnetic resonance imaging for detection of late recurrent hepatocellular carcinoma after curative treat
    Qi-Feng Chen, Sui-Xing Zhong, Ming Zhao
    Clinical and Molecular Hepatology.2026; 32(2): e175.     CrossRef
  • Interreader Agreement for Individual Ancillary Features in LI-RADS CT/MRI Version 2018: A Systematic Review and Meta-Analysis
    Yong Jun Jung, Sang Hyun Choi, Subin Heo, Dong Hwan Kim, Suk Kim, Seung Baek Hong
    American Journal of Roentgenology.2026;[Epub]     CrossRef
  • HCC surveillance after curative treatment: A new frontier for abbreviated MRI: Editorial on “Non-contrast magnetic resonance imaging for detection of late recurrent hepatocellular carcinoma after curative treatment: a prospective multicenter comparison to
    Hyungjin Rhee, Jin-Young Choi
    Clinical and Molecular Hepatology.2026; 32(2): 939.     CrossRef
  • Revisiting the role of non-contrast MRI in recurrent HCC: Bridging diagnostic performance and real-world applicability: Letter to the editor on “Non-contrast MRI for detection of late recurrent hepatocellular carcinoma after curative treatment: A prospect
    Lu Sun, Xin Zhang
    Clinical and Molecular Hepatology.2026; 32(2): e172.     CrossRef
  • Multicentre prospective trial of abbreviated MRI using gadoxetic acid versus CT for detection of late recurrent HCC (AMRICT): study protocol
    Hyo Jung Park, Dong Ho Lee, Won Chang, Hae Young Kim, Dong Hwan Kim, Won-Mook Choi, Sung Won Chung, Jonggi Choi, Danbi Lee, Ju Hyun Shim, Han Chu Lee, Young-Suk Lim, Seon-Ok Kim, Amit G Singal, So Yeon Kim
    BMJ Open.2026; 16(4): e116809.     CrossRef
  • The Use of Non‐Contrast Abbreviated MRI for the Detection of Recurrent Hepatocellular Carcinoma in Postoperative Surveillance
    Jianwei Chen, Yuemin Zhu, Dechun Zheng, Liting Wen, Juyi Wu, Qiuyuan Yue, Zhuting Fang
    Journal of Magnetic Resonance Imaging.2026;[Epub]     CrossRef
  • Performance of GAAD and GALAD Biomarker Panels for HCC Detection in Patients with MASLD or ALD Cirrhosis
    Mohammad Jarrah, Sneha Deodhar, Lisa Quirk, Mohammed Al-Hasan, Ashish Sharma, Guruveer Bhamra, Julia Terrell, Fasiha Kanwal, Yujin Hoshida, Nicole E. Rich, Purva Gopal, Amit G. Singal
    Cancers.2025; 17(23): 3835.     CrossRef
  • 9,394 View
  • 228 Download
  • 12 Web of Science
  • Crossref
Case Report

Viral hepatitis

Reversible splenial lesion on the corpus callosum in nonfulminant hepatitis A presenting as encephalopathy
Soon Young Ko, Byung Kook Kim, Dong Wook Kim, Jeong Han Kim, Won Hyeok Choe, Hee Yeon Seo, So Young Kwon
Clin Mol Hepatol 2014;20(4):398-401.
Published online December 24, 2014
DOI: https://doi.org/10.3350/cmh.2014.20.4.398

Reversible focal lesions on the splenium of the corpus callosum (SCC) have been reported in patients with mild encephalitis/encephalopathy caused by various infectious agents, such as influenza, mumps, adenovirus, Varicella zoster, Escherichia coli, Legionella pneumophila, and Staphylococcus aureus. We report a case of a reversible SCC lesion causing reversible encephalopathy in nonfulminant hepatitis A. A 30-year-old healthy male with dysarthria and fever was admitted to our hospital. After admission his mental status became confused, and so we performed electroencephalography (EEG) and magnetic resonance imaging (MRI) of the brain, which revealed an intensified signal on diffusion-weighted imaging (DWI) at the SCC. His mental status improved 5 days after admission, and the SCC lesion had completely disappeared 15 days after admission.

Citations

Citations to this article as recorded by  Crossref logo
  • A rare cause of dysarthria: Legionnaires’ disease
    Emine Afsin, Furkan Küçük, Serpil Yıldız, Sadettin Ersoy
    International Journal of Neuroscience.2025; 135(2): 168.     CrossRef
  • Clinical Characteristics of H1N1 Influenza A-Associated Mild Encephalopathy with Reversible Splenial Lesion: 4 Pediatric Cases
    Xu-fang Li, Bin Ai, Jia-wei Ye, Li-mei Tan, Hua-mei Yang, Chun-xiao Fang, Lan-hui She, Yi Xu
    Current Medical Science.2021; 41(4): 815.     CrossRef
  • Corpus Callosum Involvement as Extrahepatic Manifestation of Hepatitis E Virus: An Uncommon Entity
    Monika Singla, Parth Bansal, Venkatesh Sajja, Kapil Dev
    Journal of Neurosciences in Rural Practice.2021; 12: 427.     CrossRef
  • Reversible Splenial Lesion Syndrome with Some Novel Causes and Clinical Manifestations
    Pei-lin Lu, John F. Hodes, Xu Zheng, Xing-yue Hu
    Internal Medicine.2020; 59(20): 2471.     CrossRef
  • Electroencephalogram Abnormalities in Very Young Children with Acute Hepatitis A Infection: A Cross-Sectional Study
    Iraj Shahramian, Mohammad Hassan Mohammadi, Alireza Akbari, Alireza Sargazi, Mojtaba Delaramnasab, Ali Bazi
    Journal of Comprehensive Pediatrics.2019;[Epub]     CrossRef
  • Legionnaires Disease With Focal Neurologic Deficits and a Reversible Lesion in the Splenium of the Corpus Callosum
    Jillian E. Raybould, Megan E. Conroy, Joseph G. Timpone, Princy N. Kumar
    Infectious Diseases in Clinical Practice.2017; 25(1): 13.     CrossRef
  • MR imaging of adult acute infectious encephalitis
    A. Bertrand, D. Leclercq, L. Martinez-Almoyna, N. Girard, J.-P. Stahl, T. De-Broucker
    Médecine et Maladies Infectieuses.2017; 47(3): 195.     CrossRef
  • Mild encephalitis/encephalopathy with reversible splenial lesion (MERS) in adults-a case report and literature review
    Junliang Yuan, Shuna Yang, Shuangkun Wang, Wei Qin, Lei Yang, Wenli Hu
    BMC Neurology.2017;[Epub]     CrossRef
  • Clinically mild encephalitis/encephalopathy with a reversible splenial lesion caused by methicillin-sensitive Staphylococcus aureus bacteremia with toxic shock syndrome: a case report
    Koki Kosami, Tsuneaki Kenzaka, Yuka Sagara, Kensuke Minami, Masami Matsumura
    BMC Infectious Diseases.2016;[Epub]     CrossRef
  • Reversible splenial lesion syndrome associated with lobar pneumonia
    Chunrong Li, Xiujuan Wu, Hehe Qi, Yanwei Cheng, Bing Zhang, Hongwei Zhou, Xiaohong Lv, Kangding Liu, Hong-Liang Zhang
    Medicine.2016; 95(39): e4798.     CrossRef
  • 11,027 View
  • 121 Download
  • 11 Web of Science
  • Crossref